日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study

利布利珠单抗可改善既往接受过度普利尤单抗治疗的中重度特应性皮炎患者的临床表现、症状和生活质量:ADapt 研究结果

Silverberg, Jonathan I; Ackerman, Lindsay; Bagel, Jerry; Stein Gold, Linda; Blauvelt, Andrew; Rosmarin, David; Chovatiya, Raj; Zirwas, Matthew; Yosipovitch, Gil; Waibel, Jill; Murase, Jenny E; Lockshin, Ben; Weisman, Jamie; Atwater, Amber Reck; Proper, Jennifer; Silk, Maria; Pierce, Evangeline; Piruzeli, Maria Lucia Buziqui; Montmayeur, Sonia; Schuster, Christopher; Zhong, Jinglin; Rueda, Maria Jose; Pillai, Sreekumar; Simpson, Eric

Exploring New Dimensions in Longitudinal Rosacea Management

探索玫瑰痤疮纵向管理的新维度

Schaller, Martin; Welsh, Belinda; Micali, Giuseppe; Tan, Jerry; Del Rosso, James; Harper, Julie; Dirschka, Thomas; Cho, Soyun; Almeida, Luiz M C; Kon, Khen; Barańska-Rybak, Wioletta; Dayrit, Johannes; Stein Gold, Linda

Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States

美国慢性手部湿疹诊断和治疗的专家建议

Silverberg, Jonathan I; Cohen, David; Guttman-Yassky, Emma; Eichenfield, Lawrence F; Simpson, Eric L; Armstrong, April; Yu, JiaDe; Stein-Gold, Linda; Ehst, Benjamin D; Begolka, Wendy Smith; Bunick, Christopher G; Chovatiya, Raj

Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial

古塞库单抗治疗中重度头皮银屑病(适用于所有肤色):VISIBLE随机临床试验的B组

McMichael, Amy; Shahriari, Mona; Stein Gold, Linda; Alkousakis, Theodore; Choi, Olivia; Bhutani, Tina; Rodriguez, Adrian O; Tyring, Stephen K; Chan, Daphne; Rowland, Katelyn; Albrecht, Lorne; Lynde, Charles; Yadav, Geeta; Yeung, Jensen; Park-Wyllie, Laura; Ma, Tony; Jeyarajah, Jenny; Gao, Long-Long; Smith, Stacy; Moore, Angela Y; Vashi, Neelam; Kindred, Chesahna; Grimes, Pearl; Desai, Seemal R; Taylor, Susan C; Alexis, Andrew

Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials

口服低剂量米诺环素制剂DFD-29治疗玫瑰痤疮的疗效、安全性和耐受性:两项3期随机临床试验

Bhatia, Neal; Del Rosso, James; Stein Gold, Linda; Lain, Edward; Draelos, Zoe Diana; Sidgiddi, Srinivas

A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2-11 Years with Moderate to Severe Atopic Dermatitis

鲁索替尼乳膏治疗2-11岁中重度特应性皮炎患儿的最大剂量试验

Stein Gold, Linda; Bissonnette, Robert; Forman, Seth; Zaenglein, Andrea; Kuo, YuTzu; Angel, Brett; Chen, Xuejun; Kallender, Howard; Paller, Amy S

Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry

根据基线体表面积受累情况划分的接受生物制剂治疗的患者报告结局:来自CorEvitas银屑病注册研究的结果

Armstrong, April W; Feldman, Steven R; Fitzgerald, Timothy; Alkousakis, Theodore; Sima, Adam; Li, Alvin; Kang, Hyung-Joo; Main, Sandra I; Khattri, Saakshi; Stein Gold, Linda

The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)

一项为期 16 周的开放标签单臂 3 期研究 (INJECZTRA) 表明,Tralokinumab 预填充注射笔可改善中重度特应性皮炎成人和青少年患者的特应性皮炎体征和症状,且耐受性良好。

Soung, Jennifer; Laquer, Vivian; Zirwas, Matthew; van Iperen, Peter; Stinson, John C; Albertsen, Katrine Lykke; Stein Gold, Linda

Management of Challenging Psoriasis Clinical Scenarios

应对棘手的银屑病临床病例

Stein Gold, Linda; Alexis, Andrew; Glick, Brad P; Shahriari, Mona; Song, Eingun James; Strober, Bruce; Watch, Najat M; Young, Melodie

Oral Peptide Therapeutics as an Emerging Treatment Modality in Immune-Mediated Inflammatory Diseases: A Narrative Review

口服肽类药物作为免疫介导炎症性疾病的新兴治疗方式:综述

Stein Gold, Linda; Eyerich, Kilian; Merola, Joseph F; Torres, Joana; Coates, Laura C; Allegretti, Jessica R